EDIT:NASDAQ
Editas Medicine Inc
US$1.87
0.00%
(0.00) 1D
US$1.90
arrow_upward
+1.60% (+0.030)todayPre-market
Closed: ኖቬም 16, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Mkt. cap
288.62 ሚ
Avg. vol.
2.41 ሚ
Volume
11.35 ሺ
52-wk high
US$3.94
52-wk low
US$1.66
EPS
-US$0.62
Beta
2.09
Shares outstanding
154.34 ሚ
No. of employees
87
Mkt. cap
288.62 ሚ
Avg. vol.
2.41 ሚ
Volume
11.35 ሺ
52-wk high
US$3.94
52-wk low
US$1.66
EPS
-US$0.62
Beta
2.09
Shares outstanding
154.34 ሚ
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
ከ47 ደቂቃዎች በፊት
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
FOREX.com
·
ከ1 ሰዓት በፊት
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Investing.com
·
ከ1 ሰዓት በፊት
Why Goldman Sachs expects the S&P 500 to rally in 2027
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedኖቬም 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com